New research finds link between obesity and breast cancer risks

New research from the University of Oklahoma suggests that the biological environment within the bodies of women living with obesity may actively promote the progression of breast cancer. While the link between obesity and increased disease risk is well-established, these findings offer a deeper look at how the cellular environment helps tumors become invasive and more advanced.

The study highlights specific shifts in both the tumor cells and the surrounding tissue. Researchers observed higher levels of an enzyme known as Sulfatase 2 within tumor cells. This protein, which accelerates chemical reactions in the body, has previously been associated with various cancers, including lung and liver forms.

Understanding the Biological Mechanism

The research identified two primary changes occurring in patients with obesity. First, the environment surrounding the cancer site appeared more inflamed, characterized by an influx of immune cells. While these cells typically serve to fight disease, they can be reprogrammed by tumors to support growth, according to Memorial Sloan Kettering Cancer centre.

Second, the tumor cells themselves displayed an enhanced ability to survive under stress. These differences between the tumor and the surrounding cells suggest that the internal environment in women with obesity may be uniquely conducive to cancer survival and proliferation. Bethany Hannafon, an assistant professor at the University of Oklahoma College of Medicine, noted that these cellular changes allow cancer cells to “survive and thrive.”

Did You Know? Invasive ductal carcinoma is the most common form of breast cancer, accounting for 80 percent of all invasive cases, while invasive lobular carcinoma makes up 10 percent.

Implications for Clinical Treatment

Despite improvements in breast cancer survival rates over the last two decades, the number of annual diagnoses for invasive breast cancer remains high. The American Cancer Society estimates that 321,910 new cases of invasive breast cancer will be diagnosed this year. Currently, there is no reliable method to determine which noninvasive tumors will eventually become invasive.

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker A…

This diagnostic gap frequently leads to overtreatment. Many patients with noninvasive breast cancer undergo the same rigorous protocols as those with invasive ductal carcinoma, including surgery, radiation, and hormone therapy. Hannafon suggests that if researchers can better define these risk factors, it could eventually lead to a reduction in unnecessary medical interventions.

Expert Insight: The research underscores a critical shift in oncology: moving beyond the tumor itself to understand how the patient’s systemic health—specifically the inflammatory and enzymatic environment created by obesity—dictates disease behavior. If these findings are validated in further studies, they could fundamentally change how we stratify patient risk and personalize treatment paths to avoid the physical and psychological toll of overtreatment.

Future Outlook

Future research will likely focus on the specific role of Sulfatase 2 in the development of invasive breast cancer. As scientists continue to explore how these cellular changes contribute to tumor progression, a possible next step could be the development of new diagnostic tools. Such advancements may eventually allow clinicians to differentiate between tumors that require aggressive intervention and those that do not.

Frequently Asked Questions

What is the role of Sulfatase 2 in breast cancer?
Researchers discovered higher levels of this enzyme in tumor cells of women with obesity. It is a protein that accelerates chemical reactions and has been previously linked to various forms of cancer.

Why is overtreatment a concern for breast cancer patients?
Because there is currently no way to determine which noninvasive tumors will turn invasive, many patients receive intensive treatments like surgery and radiation that may be unnecessary.

How do immune cells contribute to tumor growth?
In women with obesity, immune cells arrive at the site of the tumor due to increased inflammation. These cells can be reprogrammed by the tumor to support its growth rather than fighting the disease.

How do you believe advancements in understanding cellular environments will change the future of personalized cancer care?